Adicet Bio ACET
NASDAQ ACET
$9.19 -0.19 (-2.03%)
At close: Aug 21, 2026 · 4:00 PM EDT

Adicet Bio (ACET) Construction in Progress (2020 - 2024)

Adicet Bio (ACET) posted quarterly Construction in Progress of $100000.0 for Q4 2024, down 98.89% year-over-year from $9.0 million in Q1 2024, and down 98.89% quarter-over-quarter from $9.0 million in Q4 2023.

Adicet Bio (ACET) Construction in Progress (2020 - 2024) Analysis & Trends

Adicet Bio's Construction in Progress history runs 5 years deep, the most recent figure standing at $100000.0 for Q4 2024.

  • In Q4 2024, Construction in Progress fell 98.89% year-over-year to $100000.0; the TTM figure through Dec 2024 stood at $100000.0 (down 98.89% YoY), while the FY2024 annual figure was $100000.0, down 98.89% from the prior year.
  • Construction in Progress for Q4 2024 stood at $100000.0, down from $9.0 million in the prior quarter.
  • The five-year high for Construction in Progress was $9.3 million in Q4 2022, with the low at $100000.0 in Q4 2024.
  • The 5-year median for Construction in Progress is $1.6 million (2023), against an average of $3.1 million.
  • The sharpest annual moves came in 2023 and 2024: Construction in Progress retreated 3.23% in 2023, then slumped 98.89% in 2024.
  • Adicet Bio's Construction in Progress stood at $1.2 million in 2020, then tumbled by 38.66% to $730000.0 in 2021, then soared by 1173.97% to $9.3 million in 2022, then dropped by 3.23% to $9.0 million in 2023, then plunged by 98.89% to $100000.0 in 2024.
  • Business Quant data shows ACET's Construction in Progress at $100000.0 in Q4 2024, $9.0 million in Q4 2023, and $500000.0 in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 152.67 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Adicet Bio 98.21 Mn -19.98 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 100,000.00
Dec 31, 2023 9.00 Mn
Sep 30, 2023 500,000.00
Jun 30, 2023 1.60 Mn
Mar 31, 2023 1.80 Mn
Dec 31, 2022 9.30 Mn
Mar 31, 2021 730,000.00
Dec 31, 2020 1.19 Mn
Sep 30, 2020 3.49 Mn